As of June 24, 2025, Universal Health International Group Holding Ltd (2211.HK) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Universal Health International Group Holding Ltd's Forward P/E to Peers
To better understand Universal Health International Group Holding Ltd's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Universal Health International Group Holding Ltd (2211.HK) | - |
| Huadong Medicine Co Ltd (000963.SZ) | 20.23 |
| C.Q. Pharmaceutical Holding Co Ltd (000950.SZ) | 14.97 |
| Shanghai Pharmaceuticals Holding Co Ltd (601607.SS) | 13.06 |
| Tibet Rhodiola Pharmaceutical Holding Co (600211.SS) | 12.37 |
| China National Accord Medicines Corp Ltd (000028.SZ) | 11.08 |
Compared to its competitors, Universal Health International Group Holding Ltd's Forward P/E is difficult to compare due to insufficient data.